+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review

Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review

Journal of the Medical Association of Thailand 90(5): 977-981

Background. Recombinant activated factor VII is used for the treatment in patients with inherited or acquired hemophilia with inhibitors and congenital factor VII deficiencies.Objective: Using recombinant activated factor VII in primary postpartum hemorrhage.Material and Method: Two cases of women who had postpartum hemorrhage and were treated with recombinant activated factor VII after all conventional treatment failed.Results: The intractable hemorrhage stopped after treatment with recombinant activated factor VII.Conclusion: The present report showed that massive postpartum hemorrhage that failed to all procedures was controlled successfully by recombinant activated factor VII.

(PDF emailed within 1 workday: $29.90)

Accession: 015645994

Download citation: RISBibTeXText

PMID: 17596055

Related references

Effectiveness of Recombinant Activated Factor VII (rFVII a) for Controlling Intractable Postpartum Bleeding in a case of Dengue Hemorrhagic Fever. Journal of Obstetrics and Gynaecology of India 66(3): 188-191, 2016

Timely 'off-label' use of recombinant activated factor VII (NovoSeven(®)) can help in avoiding hysterectomy in intractable obstetric bleeding complicated with disseminated intravascular coagulation: A case report and review of the literature. Indian Journal of Anaesthesia 56(1): 69-71, 2012

Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature. Journal of Neurosurgery 104(1 Suppl): 55-58, 2006

Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review. Critical Care 17(2): R55-R55, 2015

Recombinant factor VIIa for the treatment of acute promyelocytic leukemia with severe bleeding: 8 cases report and literature review. Zhonghua Xue Ye Xue Za Zhi 36(2): 158-160, 2015

Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. Report of three cases and review of the literature. Journal of Neurosurgery 98(3): 611-616, 2003

Low-dose recombinant activated factor VII temporally stopped bleeding from small artery in severe postpartum hemorrhage: a case report. Blood Coagulation & Fibrinolysis 24(3): 344-346, 2013

Use of Activated Recombinant Factor VII in Severe Bleeding - Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding. Transfusion Medicine and HemoTherapy 39(2): 139-150, 2012

Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery?. Interactive Cardiovascular and Thoracic Surgery 5(4): 493-498, 2007

Controlling the bleeding of jejunal varices formed at the site of choledochojejunostomy: report of 2 cases and a review of the literature. Surgery Today 43(5): 550-555, 2013

Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta. Fertility and Sterility 90(5): 2012.E1-5, 2008

Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases. Blood Transfusion 13(2): 328-332, 2015

Efficacy of Recombinant Activated Factor VII for Intractable Bleeding after Cardiovascular Surgery. Kyobu Geka. Japanese Journal of Thoracic Surgery 68(9): 735-739, 2015

Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery. Anesthesia and Analgesia 94(5): 1369-70; Author Reply 1370-1, 2002

Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures. Pediatric Critical Care Medicine 8(6): 576-579, 2007